These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

706 related items for PubMed ID: 26497471

  • 1. Outcomes of kidney retransplantation in recipients with prior post-transplant lymphoproliferative disorder.
    Rouphael B, Lankireddy S, Lazaryan A, Kukla A, Ibrahim HN, Matas AJ, Issa N.
    Clin Transplant; 2016 Jan; 30(1):60-5. PubMed ID: 26497471
    [Abstract] [Full Text] [Related]

  • 2. Successful renal retransplantation after post-transplant lymphoproliferative disease.
    Karras A, Thervet E, Le Meur Y, Baudet-Bonneville V, Kessler M, Legendre C.
    Am J Transplant; 2004 Nov; 4(11):1904-9. PubMed ID: 15476493
    [Abstract] [Full Text] [Related]

  • 3. CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality.
    Rabot N, Büchler M, Foucher Y, Moreau A, Debiais C, Machet MC, Kessler M, Morelon E, Thierry A, Legendre C, Rivalan J, Kamar N, Dantal J.
    Transpl Int; 2014 Sep; 27(9):956-65. PubMed ID: 24964147
    [Abstract] [Full Text] [Related]

  • 4. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT.
    Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
    [Abstract] [Full Text] [Related]

  • 5. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
    Jain M, Badwal S, Pandey R, Srivastava A, Sharma RK, Gupta RK.
    Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
    [Abstract] [Full Text] [Related]

  • 6. Long-term follow-up of kidney transplant patients with posttransplant lymphoproliferative disorder: duration of posttransplant lymphoproliferative disorder-induced operational graft tolerance, interleukin-18 course, and results of retransplantation.
    Birkeland SA, Hamilton-Dutoit S, Bendtzen K.
    Transplantation; 2003 Jul 15; 76(1):153-8. PubMed ID: 12865802
    [Abstract] [Full Text] [Related]

  • 7. A French Cohort Study of Kidney Retransplantation after Post-Transplant Lymphoproliferative Disorders.
    Caillard S, Cellot E, Dantal J, Thaunat O, Provot F, Janbon B, Buchler M, Anglicheau D, Merville P, Lang P, Frimat L, Colosio C, Alamartine E, Kamar N, Heng AE, Durrbach A, Moal V, Rivalan J, Etienne I, Peraldi MN, Moreau A, Moulin B, French PTLD Registry.
    Clin J Am Soc Nephrol; 2017 Oct 06; 12(10):1663-1670. PubMed ID: 28818847
    [Abstract] [Full Text] [Related]

  • 8. Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients.
    Sampaio MS, Cho YW, Shah T, Bunnapradist S, Hutchinson IV.
    Nephrol Dial Transplant; 2012 Jul 06; 27(7):2971-9. PubMed ID: 22273720
    [Abstract] [Full Text] [Related]

  • 9. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S, Zafar MN, Best J, Reddy HK.
    J Cardiovasc Pharmacol Ther; 2006 Mar 06; 11(1):77-83. PubMed ID: 16703222
    [Abstract] [Full Text] [Related]

  • 10. Posttransplant lymphoproliferative disorders in renal allograft recipients: report of 53 cases of a French multicenter study. PTLD French Working Group.
    Caillard S, Lachat V, Moulin B.
    Transpl Int; 2000 Mar 06; 13 Suppl 1():S388-93. PubMed ID: 11112039
    [Abstract] [Full Text] [Related]

  • 11. Post-transplantation lymphoproliferative disorder in pediatric kidney-transplant recipients - a national study.
    Cleper R, Ben Shalom E, Landau D, Weissman I, Krause I, Konen O, Rahamimov R, Mor E, Bar-Nathan N, Frishberg Y, Davidovits M.
    Pediatr Transplant; 2012 Sep 06; 16(6):619-26. PubMed ID: 22708682
    [Abstract] [Full Text] [Related]

  • 12. Reduction of immunosuppression for post-transplant lymphoproliferative disorder (PTLD): a single-center experience of allograft survival outcomes.
    Pan K, Franke AJ, Skelton WP, Bishnoi R, Shah C, Dang NH, Alquadan K.
    Leuk Lymphoma; 2021 May 06; 62(5):1123-1128. PubMed ID: 33327817
    [Abstract] [Full Text] [Related]

  • 13. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.
    Hosseini-Moghaddam SM, Alhomayeed B, Soliman N, Weir MA, House AA.
    Transpl Infect Dis; 2016 Jun 06; 18(3):423-30. PubMed ID: 27016725
    [Abstract] [Full Text] [Related]

  • 14. Induction regimens and post-transplantation lymphoproliferative disorder after pediatric intestinal transplantation: Single-center experience.
    Devine K, Ranganathan S, Mazariegos G, Bond G, Soltys K, Ganoza A, Sun Q, Sindhi R.
    Pediatr Transplant; 2020 Aug 06; 24(5):e13723. PubMed ID: 32424963
    [Abstract] [Full Text] [Related]

  • 15. Maintaining calcineurin inhibition after the diagnosis of post-transplant lymphoproliferative disorder improves renal graft survival.
    Serre JE, Michonneau D, Bachy E, Noël LH, Dubois V, Suberbielle C, Kreis H, Legendre C, Mamzer-Bruneel MF, Morelon E, Thaunat O.
    Kidney Int; 2014 Jan 06; 85(1):182-90. PubMed ID: 23802193
    [Abstract] [Full Text] [Related]

  • 16. [Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases].
    Chen DB, Wang Y, Song QJ, Shen DH.
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep 06; 41(9):607-12. PubMed ID: 23157829
    [Abstract] [Full Text] [Related]

  • 17. Management and outcome of liver recipients with post-transplant lymphoproliferative disease.
    Glez-Chamorro A, Jimenez C, Moreno-Glez E, Glez-Pinto I, Loinaz C, Gomez R, Garcia I, Alonso O, Palma F, Grande C.
    Hepatogastroenterology; 2000 Sep 06; 47(31):211-9. PubMed ID: 10690611
    [Abstract] [Full Text] [Related]

  • 18. Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience.
    Pinho-Apezzato ML, Tannuri U, Tannuri AC, Mello ES, Lima F, Gibelli NE, Santos MM, Ayoub AA, Maksoud-Filho JG, Velhote MC, Silva MM, Andrade WC, Miyatani HT.
    Transplant Proc; 2010 Jun 06; 42(5):1763-8. PubMed ID: 20620519
    [Abstract] [Full Text] [Related]

  • 19. Posttransplant lymphoproliferative disorder in pediatric renal transplantation.
    Srivastava T, Zwick DL, Rothberg PG, Warady BA.
    Pediatr Nephrol; 1999 Nov 06; 13(9):748-54. PubMed ID: 10603113
    [Abstract] [Full Text] [Related]

  • 20. Post-transplant lymphoproliferative disorder following pediatric heart transplantation.
    Mendoza F, Kunitake H, Laks H, Odim J.
    Pediatr Transplant; 2006 Feb 06; 10(1):60-6. PubMed ID: 16499589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.